Immediate Impact

22 standout
Sub-graph 1 of 10

Citing Papers

Emerging Therapeutic Strategies to Overcome Drug Resistance in Cancer Cells
2024 Standout
Cancer biomarkers: Emerging trends and clinical implications for personalized treatment
2024 Standout
2 intermediate papers

Works of M. Saar being referenced

ESMO International Consortium Study on the availability, out-of-pocket costs and accessibility of antineoplastic medicines in countries outside of Europe
2017
ESMO European Consortium Study on the availability, out-of-pocket costs and accessibility of antineoplastic medicines in Europe
2016

Author Peers

Author Last Decade Papers Cites
M. Saar 52 92 133 10 268
Tamy Kim 30 82 171 13 294
Sara Francescon 32 90 34 9 241
Victoria Kaestner 58 154 46 6 303
Benjamin P. Falit 44 55 123 14 323
Lisel Koepl 86 152 44 12 315
Hans‐Peter Goertz 40 81 34 17 314
Grace Hsu 67 74 63 13 256
Raymond Henderson 52 63 67 14 321
Shanda Finnigan 27 93 66 18 284
Christiaan Stevens 52 76 40 14 224

All Works

Loading papers...

Rankless by CCL
2026